CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test
The CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test is a vital diagnostic tool that helps in assessing genetic risks associated with certain types of cancer. This test is particularly important for individuals with a family history of endocrine neoplasia, as it can provide critical information about their susceptibility to cancer.
What the Test Measures
This test specifically analyzes the CDKN2B gene, which is known to play a significant role in the regulation of cell growth and division. Mutations in this gene can lead to uncontrolled cell proliferation, resulting in various forms of cancer.
Who Should Consider This Test?
Individuals who should consider the CDKN2B Gene test include:
- Those with a family history of multiple endocrine neoplasia type 1.
- Patients experiencing symptoms related to endocrine tumors.
- Individuals with known mutations in the CDKN2B gene in their family.
Benefits of Taking the Test
- Early detection of genetic predisposition to cancer.
- Informed decision-making regarding preventive measures.
- Guidance for family members on their genetic risks.
Understanding Your Results
Upon receiving your test results, it is essential to consult with a genetic counselor or oncologist. They can provide insights into the implications of your results and discuss potential next steps for monitoring or treatment.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Booking Your Test
The CDKN2B Gene Multiple Endocrine Neoplasia Type 1 CDKN2B Related NGS Genetic DNA Test is available at DNA Labs Kenya. We have branches across major cities and offer home sample collection services for your convenience. To book your test, please call or WhatsApp us at +254711564616. Your health is our priority!
Turnaround time for the test is approximately 3 to 4 weeks, and it requires a blood sample or extracted DNA. Prior to testing, a genetic counseling session is recommended to draw a pedigree chart of family members affected by the CDKN2B gene.
